Patents by Inventor Bertrand Bonnaud

Bertrand Bonnaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for in vitro diagnosis or prognosis of testicular cancer
    Patent number: 11085091
    Abstract: The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: August 10, 2021
    Assignee: BIOMERIEUX
    Inventors: Maud Arsac, Bertrand Bonnaud, Francois Mallet, Jean-Philippe Pichon
  • METHOD FOR IN VITRO DIAGNOSIS OR PROGNOSIS OF TESTICULAR CANCER
    Publication number: 20190203306
    Abstract: The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.
    Type: Application
    Filed: March 14, 2019
    Publication date: July 4, 2019
    Applicant: BIOMERIEUX
    Inventors: Maud Arsac, Bertrand Bonnaud, Francois Mallet, Jean-Philippe Pichon
  • Method for in vitro diagnosis or prognosis of testicular cancer
    Patent number: 10240213
    Abstract: The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: March 26, 2019
    Assignee: BIOMERIEUX
    Inventors: Maud Arsac, Bertrand Bonnaud, Francois Mallet, Jean-Philippe Pichon
  • Method for in vitro diagnosis or prognosis of testicular cancer
    Publication number: 20120040854
    Abstract: The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.
    Type: Application
    Filed: September 23, 2011
    Publication date: February 16, 2012
    Applicant: BIOMERIEUX
    Inventors: Maud Arsac, Bertrand Bonnaud, François Mallet, Jean-Philippe Pichon
  • METHOD FOR IN VITRO DIAGNOSIS OR PROGNOSIS OF TESTICULAR CANCER
    Publication number: 20100330581
    Abstract: The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.
    Type: Application
    Filed: March 10, 2009
    Publication date: December 30, 2010
    Applicant: Biomerieux
    Inventors: Maud Arsac, Bertrand Bonnaud, Francois Mallet, Jean-Philippe Pichon